MY145885A - Controlled release formulations for oral administration - Google Patents

Controlled release formulations for oral administration

Info

Publication number
MY145885A
MY145885A MYPI20023136A MYPI20023136A MY145885A MY 145885 A MY145885 A MY 145885A MY PI20023136 A MYPI20023136 A MY PI20023136A MY PI20023136 A MYPI20023136 A MY PI20023136A MY 145885 A MY145885 A MY 145885A
Authority
MY
Malaysia
Prior art keywords
controlled release
oral administration
release formulations
pharmaceutically
composition
Prior art date
Application number
MYPI20023136A
Inventor
Vishwanathan Narayanan Badri
Rajeev S Raghuvanshi
Mukherji Gour
Rampal Ashok
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of MY145885A publication Critical patent/MY145885A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A PHARMACEUTICAL COMPOSITION IN THE FORM OF AN ORAL CONTROLLED RELEASE SOLID DOSAGE FORM COMPRISING AN EFFECTIVE AMOUNT OF DRUG, OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS. IT ALSO RELATES TO A PHARMACEUTICALLY COMPOSITION THAT IS SUITABLE FOR ONCE-A-DAY DOSING REGIMEN.
MYPI20023136A 2001-08-24 2002-08-24 Controlled release formulations for oral administration MY145885A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN881DE2001 2001-08-24

Publications (1)

Publication Number Publication Date
MY145885A true MY145885A (en) 2012-05-15

Family

ID=42632567

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20023136A MY145885A (en) 2001-08-24 2002-08-24 Controlled release formulations for oral administration

Country Status (2)

Country Link
AR (1) AR036360A1 (en)
MY (1) MY145885A (en)

Also Published As

Publication number Publication date
AR036360A1 (en) 2004-09-01

Similar Documents

Publication Publication Date Title
AP2003002763A0 (en) Controlled release formulations for oral administration
TW200500098A (en) Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
AP1954A (en) Controlled release compositions comprising nimesulide.
MX2007015480A (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption.
TW200505498A (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
UA84266C2 (en) Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyroolidon as excipient, processes for the preparation and use thereof
DE60032749D1 (en) STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING AN NON-TEROID INFUSE-INFLAMMATIVE AGGREGATE AND PROSTAGLANDIN
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
NO20030897L (en) Process for the preparation of pharmaceutical compositions for use with wet gelatin formulations
ATE298324T1 (en) DEUTERATED 3-PIPERIDINOPROPIOPHENONE AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
EP0966966A3 (en) Nefazodone dosage form
PT1411921E (en) Pharmaceutical compositions containing terbinafine and use thereof
ATE287264T1 (en) ORAL MEDICINAL PRODUCTS CONTAINING BUPRENORPHINE
BR0013719A (en) Controlled-release oral dosage, suitable for oral administration
BR0112847A (en) Use of a solid dosage form
MXPA06000332A (en) Novel solid pharmaceutical composition comprising amisulpride.
HUP0203148A2 (en) Orally distintegrating composition comprising mirtazapine
SG145717A1 (en) Composition for releasing a weak base for an extended period of time
BR0014440A (en) Oral controlled release formulations
MY145885A (en) Controlled release formulations for oral administration
YU81101A (en) Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
IL155855A0 (en) Pharmaceutical formulation of gepirone for oral administration
EA200701091A1 (en) OPTICAL PHARMACEUTICALS
DE50311479D1 (en) PHARMACEUTICAL COMPOSITION, CONTAINING OXCARBAZEPINE WITH CONTROLLED ACTIVE INGREDIENTS